society schizophrenia 
STAT
FEBRUARY 28, 2024
Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic. Efforts to one-up the last generation of drugs mostly resulted in incremental changes to aging medicines.
Pharma Marketing Network
MARCH 23, 2023
Examples: A well-known example of a disease awareness campaign is the “Janssen” campaign, which aimed to raise awareness about Schizophrenia and the treatment options available. These campaigns are usually focused on educating the public about a disease or condition and the treatments available, and not just promoting a specific drug.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
MARCH 25, 2023
Examples: A well-known example of a disease awareness campaign is the “Janssen” campaign, which aimed to raise awareness about Schizophrenia and the treatment options available. These campaigns are usually focused on educating the public about a disease or condition and the treatments available, and not just promoting a specific drug.
European Pharmaceutical Review
APRIL 13, 2023
As psychedelics diffused into wider society and recreational use increased, some individuals reported…ongoing symptoms after the drugs had left the body” At a time when psychiatry lacked effective medical therapies, the discovery of LSD was of interest.
Pharmaceutical Technology
MARCH 7, 2023
In 2018, guidelines by the North American Menopause Society, and others, recommended selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs) as front-line medications for depression during perimenopause.
The Checkup by Singlecare
NOVEMBER 20, 2023
Amitriptyline and older adults The American Geriatrics Society (AGS) Beers Criteria® is a set of guidelines utilized to pinpoint medications that might not be suitable for older adults due to potential side effects or other complications.
Pharmaceutical Technology
JANUARY 16, 2023
The US Food and Drug Administration (FDA) has approved Luye Pharma Group’s Rykindo (risperidone) as an extended-release injectable suspension to treat schizophrenia in adult patients. In 2021, Rykindo was approved to treat schizophrenia in China.
Expert insights. Personalized for you.
143 
Let's personalize your content